Informations techniques
Exploitant
OMNIVISION GmbH
Présentation
BRIMONIDINE OMNIVISION 2 mg/ml, collyre en solution en récipients unidoses - 60 récipients unidoses de 0,35 ml (CIP : 34009 301 500 3 0)
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
UNp5S868ysCMdMYK
Français